Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trial

Diabetes Obes Metab. 2024 May;26(5):1971-1975. doi: 10.1111/dom.15477. Epub 2024 Jan 29.
No abstract available

Keywords: N‐terminal prohormone of brain natriuretic peptide; empagliflozin; myocardial infarction; prediabetes; sodium‐glucose cotransporter 2 inhibitors; type 2 diabetes.

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Benzhydryl Compounds / adverse effects
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucosides / adverse effects
  • Heart
  • Heart Failure*
  • Humans
  • Myocardial Infarction*

Substances

  • Benzhydryl Compounds
  • empagliflozin
  • Glucosides